WALTHAM, Mass., Aug. 31, 2023 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq:SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, will participate in a Targeted Oncology panel discussion at the Citi 18th Annual BioPharma Conference on Wednesday, September 6, 2023 at 1:00 p.m.
Read more at prnewswire.comSyndax Announces Participation at the Citi 18th Annual BioPharma Conference
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here